BAX and Alzheimer disease: Nonetheless, PaPE-1 normalized the Aβ-induced loss of mitochondrial membrane potential and restored the BAX/BCL2 ratio, which suggests that the anti-AD capacity of PaPE-1 particularly relies on inhibition of the mitochondrial apoptotic pathway.